GlassScriptPhysician profile
Karen E Guinn
NPI 1225168446
$5,003.39
in general payments reported to CMS, 2019-2025
10 companies · $691 in 2025
The $691 reported for 2025 was more than what 85% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $456 · 2021: $449 · 2022: $847 · 2023: $1,448 · 2024: $294 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,432.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| World Class Technology Corporation | $2,481.17 | 2019-2025 | Pitts21, Pitts21 Pro |
| Align Technology, INC. | $1,513.28 | 2019-2025 | Invisalign, Itero Element 5d Plus Lite, Invisalign First - Comprehensive |
| Dentsply Sirona INC | $368.85 | 2019 | |
| American Orthodontics Corporation | $288.92 | 2023-2025 | LP and Ifit Tubes, Empower-Metal, Radiance |
| Scican INC | $168.00 | 2019 | |
| Ormco Corporation | $81.21 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $36.31 | 2023 | Arestin |
| Forestadent USA, INC. | $25.00 | 2023 | |
| Solventum Corporation | $23.03 | 2024 | Relyx Unicem Aplicap, Scotchbond Universal, Filtek |
| Envista Holdings Corporation | $17.62 | 2025 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Guinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.